Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic
American Journal of Law & Medicine · 2021
DOI: 10.1017/amj.2021.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Law & Medicine, 2021. Verfasst von Katelynn Maxwell. Hauptthemen laut MEDLINE: Government Regulation, United States Food and Drug Administration. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
The FDA already subjects most medical devices to much less stringent approval requirements than drugs and biologics, and attempts to speed up rollout during the COVID crisis have been problematic. Agency decisions, including to allow antibody test marketing without emergency use authorization or review, and the back-and-forth guidance on laboratory-developed tests, have met harsh criticism and unreliable results. Though the long-term results of these decisions are unclear, the FDA’s credibility, reliability, and commitment to safety are threatened by even further lessening medical device regulatory oversight during the coronavirus pandemic. The relaxed and fix-it-later approach to many of the FDA’s public health emergency decisions regarding medical devices reflect the ongoing criticisms of medical device regulation in general, specifically the 510(k) process and laboratory developed test regulation, offering a point of reflection towards reform. Adaptive legislation and a risk-based and evidentiary approach to premarket and postmarket review can begin to address these issues both generally and in an emergency context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Maxwell, K. (2021). Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic. American Journal of Law & Medicine. https://doi.org/10.1017/amj.2021.18
Vancouver
Maxwell K. Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic. American Journal of Law & Medicine. 2021. doi:10.1017/amj.2021.18
BibTeX
@article{Maxwell2021,
author = {Maxwell, Katelynn},
title = {Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic},
journal = {American Journal of Law & Medicine},
year = {2021},
doi = {10.1017/amj.2021.18}
}
EUVIMED